Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 1
2010 2
2011 2
2012 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS).
Hachfeld A, Atkinson A, Calmy A, de Tejada BM, Hasse B, Paioni P, Kahlert CR, Boillat-Blanco N, Stoeckle M, Aebi-Popp K; Swiss HIV Cohort Study, the Swiss Mother, Child HIV Cohort Study (MoCHiV). Hachfeld A, et al. HIV Med. 2022 Jan;23(1):60-69. doi: 10.1111/hiv.13152. Epub 2021 Sep 2. HIV Med. 2022. PMID: 34476886 Free PMC article.
INTRODUCTION: Following the 'Swiss statement' in 2008 it became an option to omit the use of condoms in serodiscordant couples and to conceive naturally. ...METHODS: In all, 3023 women (aged 18-49 years) participating in the Swiss HIV Cohort Study were included. Obs …
INTRODUCTION: Following the 'Swiss statement' in 2008 it became an option to omit the use of condoms in serodiscordant couples and to …
Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study.
Paioni P, Aebi-Popp K, Martinez de Tejada B, Rudin C, Bernasconi E, Braun DL, Kouyos R, Wagner N, Crisinel PA, Güsewell S, Darling KEA, Duppenthaler A, Baumann M, Polli C, Fischer T, Kahlert CR; Swiss HIV Cohort Study (SHCS) and the Swiss Mother and Child HIV Cohort Study (MoCHiV). Paioni P, et al. Lancet Reg Health Eur. 2023 Jun 1;31:100656. doi: 10.1016/j.lanepe.2023.100656. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37303945 Free PMC article.
Late start of combination antiretroviral therapy (cART) during the third trimester was found to be the main risk factor for failure of retention in HIV care (crude odds ratio [OR] 3.91; 95% confidence interval [CI], 1.50-10.22; p = 0.005). Among mothers on cART until at le …
Late start of combination antiretroviral therapy (cART) during the third trimester was found to be the main risk factor for failure of reten …
Antiretroviral treatment during pregnancy.
Keiser O, Gayet-Ageron A, Rudin C, Brinkhof MW, Gremlich E, Wunder D, Drack G, Hirschel B, de Tejada BM; Swiss HIV Cohort Study (SHCS); Swiss Mother & Child HIV Cohort Study (MoCHiV). Keiser O, et al. AIDS. 2008 Nov 12;22(17):2323-30. doi: 10.1097/QAD.0b013e3283189bf1. AIDS. 2008. PMID: 18981771
We compared virologic failure and the frequency of treatment changes in pregnant and non-pregnant women of the Swiss HIV Cohort Study. METHODS: Using data on 372 pregnancies in 324 women we describe antiretroviral therapy during pregnancy. ...
We compared virologic failure and the frequency of treatment changes in pregnant and non-pregnant women of the Swiss HIV Cohort Study …
Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.
Rudin C, Spaenhauer A, Keiser O, Rickenbach M, Kind C, Aebi-Popp K, Brinkhof MW; Swiss HIV Cohort Study (SHCS); Swiss Mother & Child HIV Cohort Study (MoCHiV). Rudin C, et al. HIV Med. 2011 Apr;12(4):228-35. doi: 10.1111/j.1468-1293.2010.00876.x. Epub 2010 Aug 18. HIV Med. 2011. PMID: 20726902 Free article.
METHOD: We analysed data from 1180 pregnancies prospectively collected by the Swiss Mother and Child HIV Cohort Study (MoCHiV) and the Swiss HIV Cohort Study (SHCS). ...
METHOD: We analysed data from 1180 pregnancies prospectively collected by the Swiss Mother and Child HIV Cohort Study (MoCHiV) …
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.
Rudin C, Burri M, Shen Y, Rode R, Nadal D; Pediatric Infectious Disease Group of Switzerland; Swiss Mother and Child HIV Cohort Study (MoCHiV). Rudin C, et al. Pediatr Infect Dis J. 2008 May;27(5):431-7. doi: 10.1097/INF.0b013e3181646d5a. Pediatr Infect Dis J. 2008. PMID: 18382386
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced, initially protease inhibitor (PI)-naive, human immunodeficiency virus (HIV)-1-infected children. METHODS: HIV-1-infected children enrolled in t …
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced, ini …
Sudden infant death syndrome in infants born to HIV-infected and opiate-using mothers.
Kahlert C, Rudin C, Kind C; Swiss HIV Cohort Study (SHCS); Swiss Mother & Child HIV Cohort Study (MoCHiV). Kahlert C, et al. Arch Dis Child. 2007 Nov;92(11):1005-8. doi: 10.1136/adc.2007.117192. Epub 2007 Jun 7. Arch Dis Child. 2007. PMID: 17556395 Free PMC article.
OBJECTIVE: This study was undertaken to determine the role of opiate use during pregnancy as a predisposing factor for sudden infant death syndrome (SIDS) in infants born to HIV-infected mothers. METHODS: In order to identify all infant deaths and their cause and associati …
OBJECTIVE: This study was undertaken to determine the role of opiate use during pregnancy as a predisposing factor for sudden infant death s …
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children.
Rudin C, Wolbers M, Nadal D, Rickenbach M, Bucher HC; Pediatric Infectious Disease Group of Switzerland (PIGS); Swiss Mother and Child HIV Cohort Study (MoCHiV). Rudin C, et al. Arch Dis Child. 2010 Jun;95(6):478-81. doi: 10.1136/adc.2009.169375. Arch Dis Child. 2010. PMID: 20501542 Free article. Clinical Trial.
AIM: To evaluate the long-term safety and effectiveness of lopinavir/ritonavir (LPV/r) in a population-based cohort of HIV-1-infected children. METHODS: All children enrolled in the Swiss Mother and Child HIV Cohort Study, treated with LPV/r-based combination antire …
AIM: To evaluate the long-term safety and effectiveness of lopinavir/ritonavir (LPV/r) in a population-based cohort of HIV-1-infected childr …
Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*.
L'Huillier AG, Ferry T, Courvoisier DS, Aebi C, Cheseaux JJ, Kind C, Rudin C, Nadal D, Hirschel B, Sottas C, Siegrist CA, Posfay-Barbe KM; Pediatric Infectious Diseases Group of Switzerland; Group of Switzerland (PIGS); Swiss HIV Cohort Study (SHCS); Swiss Mother & Child HIV Cohort Study (MoCHiV). L'Huillier AG, et al. HIV Med. 2012 Jan;13(1):54-61. doi: 10.1111/j.1468-1293.2011.00936.x. Epub 2011 Jul 3. HIV Med. 2012. PMID: 21722287 Free article.
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland.
Myers C, Posfay-Barbe KM, Aebi C, Cheseaux JJ, Kind C, Rudin C, Nadal D, Siegrist CA; Pediatric Infectious Disease Group of Switzerland (PIGS); Swiss Mother and Child HIV Cohort Study (MoCHIV). Myers C, et al. Pediatr Infect Dis J. 2009 Nov;28(11):996-1001. doi: 10.1097/INF.0b013e3181a78348. Pediatr Infect Dis J. 2009. PMID: 19820427
RESULTS: Among 87 HIV-infected children (mean age: 11.1 years) followed in the 5 Swiss university hospitals and 1 regional hospital, most (76%) had CD4 T cells >25%, were receiving highly active antiretroviral treatment (79%) and had undetectable viral load (60%). ...
RESULTS: Among 87 HIV-infected children (mean age: 11.1 years) followed in the 5 Swiss university hospitals and 1 regional hospital, …